Navigation Links
ULURU Inc. Reports Financial Results for Fourth Quarter and Year Ending December 31, 2011
Date:4/2/2012

ADDISON, Texas, April 2, 2012 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) today announced its financial results for the fourth quarter and year ended December 31, 2011 and provided a review of its operating activities.

During the past 12 months significant achievements have been made by ULURU to expand the global commercialization of Altrazeal®, including:

  • Execution of an agreement to market Altrazeal® in Europe;
  • Agreement to market Altrazeal® in Australia, New Zealand, and selected Middle Eastern markets;
  • Approval to market Altrazeal® in Australia and New Zealand;
  • Commencement of clinical studies to support the cost effectiveness of Altrazeal® in treating chronic wounds; and
  • Generation of clinical data supporting the use of Altrazeal® in additional indications including diabetic foot ulcers with removable off-loading.

  • In addition, we received a patent specifically covering the wound care application of our NanoFlex™ technology which extends the patent life of Altrazeal® until 2027. This patent has also been granted in numerous international territories and is under review in other global markets.

    In the upcoming six month period our business outlook is for a significant expansion in commercial activities, including the following:

  • The first shipment of Altrazeal® to our exclusive worldwide distributor for marketing in the veterinary market;
  • The first European order for Altrazeal® has been received and will be supplied;
  • Altrazeal® is planned for launch in 5 markets including Germany, Australia and New Zealand;
  • Approval for marketing in China is scheduled to be received;
  • The first shipment of product to China is planned;
  • Launch of the 0.75 gram blister package in the United States, which is designed to expand product usage, including use in additional hospital accounts and long term car
    '/>"/>

  • SOURCE ULURU Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
    2. ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009
    3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
    4. ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference
    5. ULURU Inc. Obtains Status of Approved Supplier With McKesson.
    6. ULURU Inc. Reports Second Quarter 2010 Financial Results
    7. ULURU Inc. Announces Conference Call
    8. ULURU Inc. Provides Altrazeal® Clinical Update
    9. ULURU Inc. Reports Third Quarter 2010 Financial Results
    10. ULURU Inc. to Raise $500,000 in Registered Direct Offering
    11. ULURU Inc. Announces Agreement With Exciton to Develop Antimicrobial Dressing
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... , Dec. 24, 2014  Actavis plc (NYSE: ... Company has received a complete response letter from ... its New Drug Application (NDA) for the fixed-dose ... treatment of hypertension.   Photo - ... disappointed in the receipt of a complete response ...
    (Date:12/24/2014)... 24, 2014 Soligenix, Inc. (OTCQB: SNGX) ... developing products that address unmet medical needs in ... today that on December 24, 2014 it closed ... The Company raised approximately $2.3 million in gross ... the net proceeds from the offering to fund ...
    (Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, 2014 ... a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics ... medical need and commercial potential, today announced that ... 2,050,000 shares of its common stock and Series ... common stock.  Funds under the management of QVT ...
    Breaking Medicine Technology:Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4
    (Date:12/25/2014)... Recently, iFitDress.com, the popular online supplier of wedding dresses ... selection of black one-shoulder cocktail dresses . In addition, ... available at discounted prices, up to 70% off. ... three weeks only. You know, we have thousands of frequent ... our new items can visit our website for more details. ...
    (Date:12/25/2014)... 2014 Helen Harris’ RP (Retinitis Pigmentosa) ... California after an 8 year battle with breast cancer. ... evening in her home in Woodland Hills California after ... , As the founder and volunteer ... pioneered and championed many of today's greatest breakthroughs in ...
    (Date:12/25/2014)... News) -- Overeating is common during the holidays, but there ... expert says. "Don,t arrive at a party hungry. It ... you,ll be attending a party, but deprivation leads to hunger, ... Northern Westchester Hospital in Mount Kisco, N.Y., said in a ... the day and even to have a snack before attending ...
    (Date:12/25/2014)... (PRWEB) December 25, 2014 “ SmileStix ” ... which features the latest and coolest mobile applications on the ... expert and host of NewsWatch, conducted the app review and ... to create personal stickers. , The old saying goes, “A ... lot of words that can describe a single image, because ...
    (Date:12/24/2014)... 25, 2014 AlignLife of Wauwatosa ... afford certain items. During the holiday season, AlignLife looks forward ... 70 toys," says Dr. Sara Mahalko-Leonhardt, owner of AlignLife. "It ... joy, knowing that we are able to give kids toys ... not been for the generosity of our patients." , The ...
    Breaking Medicine News(10 mins):Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:AlignLife of Wauwatosa Brings Joy to Less Fortunate Families 2
    ... MIAMI , Feb. 12 Flowers? Check.  Chocolates?  Check. ... Valentine,s Day with the one you love, don,t let condom ...  Sensis makes applying a condom a more passionate part of the ... to help people practice safer sex while preserving the passion and ...
    ... Mich. , Feb. 12 Perrigo Company (Nasdaq: ... has granted summary judgment in its favor in patent litigation ... Mucinex® tablets. Perrigo had been sued by Adams Respiratory Therapeutics, ... Drug Application holder and patent owner. The United States District ...
    ... LAVAL , Québec and PRINCETON, NJ , Feb. 12 ... that it has priced an underwritten public offering of 11,764,706 newly issued ... Each unit is comprised of one of the Company,s common shares and ... entitles the holder to acquire one common share of the Company upon ...
    ... ... of First Lady Michelle Obama’s "Let’s Move" initiative and praised the First Lady for ... the health of America’s children and the future of our country. , ... (PRWEB) February 12, 2010 -- ...
    ... reopen clogged coronary artery , THURSDAY, Feb. 11 (HealthDay ... be "in good spirits" Thursday evening in a New ... into a clogged heart artery. , The 63-year-old Clinton, ... complaining of chest pains. , "Today President Bill Clinton ...
    ... ... high protein (35.7% per serving), zero cholesterol and zero trans fats with a good source ... diabetic, and the weight conscious. , ... Clara City, MN (PRWEB) February 10, 2010 -- With all this talk about obesity, ...
    Cached Medicine News:Health News:Sensis Condoms With QuikStrips(TM) Reminds Lovers To Protect The Passion This Valentine's Day 2Health News:Sensis Condoms With QuikStrips(TM) Reminds Lovers To Protect The Passion This Valentine's Day 3Health News:Perrigo Granted Summary Judgment of Non-Infringement in Mucinex(R) Case 2Health News:Perrigo Granted Summary Judgment of Non-Infringement in Mucinex(R) Case 3Health News:Labopharm announces pricing of US$20 million public offering of units 2Health News:Labopharm announces pricing of US$20 million public offering of units 3Health News:Labopharm announces pricing of US$20 million public offering of units 4Health News:IHRSA Heartily Applauds First Lady's "Let's Move" Initiative and Vows Support 2Health News:IHRSA Heartily Applauds First Lady's "Let's Move" Initiative and Vows Support 3Health News:IHRSA Heartily Applauds First Lady's "Let's Move" Initiative and Vows Support 4Health News:IHRSA Heartily Applauds First Lady's "Let's Move" Initiative and Vows Support 5Health News:IHRSA Heartily Applauds First Lady's "Let's Move" Initiative and Vows Support 6Health News:Ex-President Clinton Said To Be Fine After Heart Procedure 2Health News:Ex-President Clinton Said To Be Fine After Heart Procedure 3Health News:New and Delicious, Almond Butter Filled, Cookie Bites With 35.7% Protein to Help Manage Weight and Build Muscle 2
    This model of bench top refrigerated incubator has been designed to suit the TPS-32 platelet shaker....
    ELISA for detection of Anti-Gliadin IgG....
    An enzyme-linked immuno-sorbent assay for the detection and quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
    Enzyme immunoassay for the quantitative determination of Gliadin-IgG antibodies in serum and plasma. This kit provides specific determination of gliadin antibodies by using highly purified gliadin....
    Medicine Products: